메뉴 건너뛰기




Volumn 72, Issue 5, 2007, Pages 1729-1736

1,1-Dioxonaphtho[1,2-b]thiophene-2-methyloxycarbonyl (α-Nsmoc) and 3,3-dioxonaphtho[2,1-b]thiophene-2-methyloxycarbonyl (β-Nsmoc) amino-protecting groups

Author keywords

[No Author keywords available]

Indexed keywords

BSMOC RESIDUES; MICHAEL ADDITION; NAPHTHOTHIOPHENE;

EID: 33847651271     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo062397g     Document Type: Article
Times cited : (18)

References (24)
  • 3
    • 0038617265 scopus 로고    scopus 로고
    • For the use of exactly 1 equiv of a secondary amine (4- piperidinopiperidine) to deblock a sensitive Bsmoc paclitaxel derivative, see: Greenwald, R. B.; Zhao, H.; Reddy, P. J. Org. Chem. 2003, 68, 4894.
    • For the use of exactly 1 equiv of a secondary amine (4- piperidinopiperidine) to deblock a sensitive Bsmoc paclitaxel derivative, see: Greenwald, R. B.; Zhao, H.; Reddy, P. J. Org. Chem. 2003, 68, 4894.
  • 15
    • 33847680222 scopus 로고    scopus 로고
    • A similar course for the Bsmoc deblocking process was previously recorded. See the Supporting Information of ref 4a, page S13.
    • A similar course for the Bsmoc deblocking process was previously recorded. See the Supporting Information of ref 4a, page S13.
  • 24
    • 33847656334 scopus 로고    scopus 로고
    • For a general description of the syringe methodology, see ref 1
    • For a general description of the syringe methodology, see ref 1.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.